Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋

What a terrific match today for @ClevelandClinic ! Welcome, everyone. Great to see another two enrollees in our ABIM Research Pathway. #Match2026 #MedEd

Peripheral vasopressor administration in critically ill adults was associated with a low incidence of adverse events—major events were rare using short peripheral intravenous catheters, and use avoided central venous catheter placement in 60% of cases. ja.ma/4btNGSr

💙 I get emails like this every year, and it never stops being heartbreaking. 💔To everyone who didn’t match: we see you. It’s not over — it just wasn’t your time. As Batman’s dad says: “Why do we fall, Bruce?” So we can rise again. youtu.be/HIcGuFnl7ZU?si… #Match2026 #MedEd

New Mechanisms in Abdominal Aortic Aneurysms. link.springer.com/article/10.100… @ThinkAortaUS @JohnRitterFdn

Fantastic Grand Rounds from @CleClinicHVTI. Dr. David Zidar broke down the immunology–cardiology crossroads 🔬 ❤️‍🔥— and why leukopenia remains an ominous sign. Loved the nod to our Chair’s JCI paper from 31 years ago… data still true today 📚✨. content-assets.jci.org/manuscripts/11… #MedEd

The International Registry of Aortic Dissection (IRAD) turns 30 years old today. 60 Centers, nearly 18,000 patients, more than 125 publications…IRAD gives a voice to patients and families with this rare and highly dangerous problem. We can do better…no we must do better…

In this review, @PetrovaLab et al. highlight classic & recent findings detailing molecular mechanisms of organ-specific functions of blood & lymphatic intestinal vessels, including nutrient absorption, epithelial cell maintenance & immune cell recruitment. hubs.la/Q02d9LGM0

Spoke at the Mayfield Heights High School Innovation Center today, and left inspired by the Med Tech group. The curiosity and drive in these students is the kind of energy that will shape the future of medicine. (posted with permission) #MedEd

Online first: Kupniewski & colleagues show that quantitative Doppler metrics—higher FV waveform frequency and shorter CVF acceleration time—accurately identify central venous HTN, supporting a noninvasive approach during routine venous duplex US. 🔗 buff.ly/HcRb0sm

Major life hack: Be grateful. Harvard researchers found that gratitude was linked to significantly lower risk of all-cause mortality. The way you choose to perceive the world impacts every single area of your life. Choose wisely.

Proud to share @ClevelandClinic PRISM PhD student & former vascular medicine fellow @FahadAlKhalfan study. He shows metformin + aspirin are linked to slower AAA growth — and ACEi/ARBs slow growth only in women. atherosclerosis-journal.com/article/S0021-… #aorta @ThinkAorta

Yet again, a GPCR belonging to the olfactory family when ectopically expressed can teach us so much. Big paper (🤞🏻) coming from @RMLDelhi @AnuAggarwal86 soon !

A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified pig liver. go.nature.com/4d4YVmE

Very interesting given that my athlete son was recently discovered to have this. Too bad it took a face 🪴 before the work up.

DANCAVAS trial: Patients with severe aortic and iliac calcifications have a higher risk of aortic events and MALE. Quantifying aortic calcification may aid in prognosis and risk stratification in aortic aneurysm or peripheral artery disease.ahajrnls.org/40QpbtC

The first time you start a research lab, there’s no manual. So I made one. A practical toolkit for postdocs and early-career faculty launching their first lab: hiring, startup planning, collaborations, and building a sustainable research program. zenodo.org/records/188835…

In a randomized paired analysis of post-MI patients from the COLCOT trial, colchicine treatment significantly reduced the burden of clonal hematopoiesis (CH) compared w/ placebo. Further trials of anti-inflammatory strategies to modulate CH are needed. ahajrnls.org/4aOsWV6

Proud of the wee man—earned his Black Belt 3rd Dan 🥋🔥 ✅ 700 kicks in under 7 minutes ✅ 8 Taegeuk+8 Palgwe forms, Koryo, Keumgang, Taebaek ✅ 4 complex spinning/airborne breaks — 2 non‑dominant leg ✅ Live the tenets of TKD: courtesy, integrity, perseverance, self‑control

🧪🌿 Colchicine slows coronary plaque progression in stable CAD — first randomized imaging evidence A new randomized, double-blind, placebo-controlled trial in European Heart Journal – Cardiovascular Imaging tested whether low-dose colchicine — a classic anti-inflammatory drug — affects coronary plaque progression in patients with stable coronary artery disease (CAD). 📍 Study design: • 84 adults with angiographically confirmed CAD or a high coronary calcium score (>400) • Randomized to colchicine 0.5 mg/day vs placebo for 12 months • Standard care continued in both groups • Serial coronary CT angiography (CCTA) assessed plaque change 🧠 Why this matters Inflammation is a key driver of atherosclerosis progression and vulnerability. Prior clinical trials showed colchicine reduces cardiovascular events, but its direct effect on coronary plaque morphology and progression was unclear. 🫀 Key findings: • Colchicine significantly reduced progression of total plaque volume, particularly low-attenuation plaque — a marker of high-risk, lipid-rich, unstable plaque • Slower plaque progression was evident even when LDL levels were similar between groups • Treatment was generally well-tolerated at 0.5 mg daily 📊 Clinical implications: This trial provides mechanistic evidence that colchicine’s event-reducing benefits may be mediated through direct influence on plaque biology, not just systemic inflammation. Slowing plaque progression — especially of vulnerable components — aligns with reduced risk of future events. ⚠️ Nuances: • Modest sample size and single-timepoint imaging limits broad generalization • Plaque imaging biomarkers predict risk but are surrogate endpoints 📌 Bottom line: Low-dose colchicine, added to standard therapy, slows coronary atherosclerosis progression in stable CAD — supporting its emerging role in targeted residual risk reduction beyond LDL lowering.

@umarkhalidmd @LebenTefera That’s right, @LebenTefera was part of the @ccfvascmed writing committee. 🔥They quoted a couple of our papers and the PERT study from @PulkitChaudhury. A must read 🔖 for those caring for patients with high risk PE. 🫁🫀#SwotTheClot #MedEd

PERT teams should be standard of care in hospitals (Class 1). Hot off the press. ahajournals.org/doi/10.1161/CI… Congratulations @2Scottish @LebenTefera